✦ LIBER ✦

PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK NHS PERSPECTIVE

✍ Scribed by M Botteman; M Aapro; J Stephens; JW Hay; J Brandman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN4 ECONOMIC EVALUATION OF INTRAVENOUS

✍ M Botteman; M Aapro; JW Hay; J Stephens; J Brandman 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCN8 COST-EFFECTIVENESS ANALYSIS OF ORAL

✍ E De Cock; J Hutton; P Barrett-Lee; P Canney; JJ Body; M Neary; GJ Lewis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PCNII COST-EFFECTIVENESS OF ORAL IBANDRO

✍ E De Cock; J Hutton; P Barrett-Lee; P Canney; JJ Body; M Neary; GJ Lewis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB